Diabetes News

  • Designing for diabetes
    "Managing type 1 diabetes requires close monitoring of blood sugar levels throughout the day and regular injections of insulin," says Dr. McCarthy. "For young people this often poses challenges, as it can disrupt participation in everyday activities and present problems of dealing with the stigma that can surround the condition." Read more »
  • Semaglutide found to be effective against type 2 diabetes
    (HealthDay)—Semaglutide is safe and effective for the treatment of type 2 diabetes, according to a review published online May 13 in Diabetes, Obesity and Metabolism. Read more »
  • Women with pregnancy-related diabetes may be at risk for chronic kidney disease
    Gestational diabetes may predispose women to early-stage kidney damage, a precursor to chronic kidney disease, according to a study by researchers at the National Institutes of Health and other institutions. The study appears in Diabetes Care. Read more »
  • Could intermittent fasting diets increase diabetes risk?
    Fasting every other day to lose weight impairs the action of sugar-regulating hormone, insulin, which may increase diabetes risk, according to data presented in Barcelona at the European Society of Endocrinology annual meeting, ECE 2018. These findings suggest that fasting-based diets may be associated with long-term health risks and careful consideration should be made before starting such weight loss programmes. Read more »
  • U.S. nursing home costs due to diabetes vary greatly by state
    (HealthDay)—Diabetes-attributable nursing home costs are substantial, but vary greatly across the nation, according to a study published online May 14 in Diabetes Care. Read more »
  • Diabetes researchers find switch for fatty liver disease
    Duke researchers have identified a key fork in the road for the way the liver deals with carbohydrates, fats and protein. They say it could be a promising new target for combating the pandemics of fatty liver disease and prediabetes. Read more »
  • New study of youth with type 1 diabetes connects 'honeymoon period' with lower LDL cholesterol
    A new study by UMass Medical School physician-scientist Benjamin U. Nwosu, MD, finds that children with type 1 diabetes who experienced a partial clinical remission, or "honeymoon phase," had significantly lower low-density lipoprotein (LDL), or "bad" cholesterol, five years after diagnosis. The honeymoon period is the brief period when some children with new onset type 1 diabetes are able to produce some insulin resulting in improved glucose control. This new finding makes the case for initiating lipid profile monitoring when type 1 diabetes is first diagnosed, rather than waiting for as much as five years, as recommended by current clinical guidelines. Read more »
  • "Living drug factories" may one day replace injections
    Patients with diabetes generally rely on constant injections of insulin to control their disease. But MIT spinout Sigilon Therapeutics is developing an implantable, insulin-producing device that may one day make injections obsolete. Read more »
  • Dual-hormone system may lower time in hypoglycemia in T1DM
    (HealthDay)—For physically active adults with type 1 diabetes, the addition of glucagon delivery to a closed-loop system using wearable sensors with automated exercise detection is associated with reduced hypoglycemia, according to a study published online May 11 in Diabetes Care. Read more »
  • New medicare perk: diabetes prevention
    (HealthDay)—Millions of U.S. seniors can now take part in a Medicare program designed to prevent prediabetes from progressing to type 2 diabetes. Read more »
  • CrossFit improves how people with type 2 diabetes can control blood sugar levels
    New research published in Experimental Physiology has suggested a 6-week CrossFit exercise programme can lead to improved control of blood sugar levels and decreased risk of heart disease in people with Type 2 diabetes. Read more »
  • Patients, health care workers call for affordable insulin
    Activists are rallying in Massachusetts, demanding more affordable insulin. Read more »
  • New research project Hypo-RESOLVE investigates hypoglycaemia and its impact in diabetes
    Within the newly started European research project Hypo-RESOLVE, 23 leading international players from academia, industry and civil society have joined forces to find better solutions to alleviate the burden and consequences of hypoglycaemia in diabetes. The international consortium aims to provide evidence-based classification of hypoglycaemia to achieve better treatments for people living with diabetes. Diabetes is a global pandemic, currently affecting around 60 million people in Europe. Read more »
  • Gestational diabetes may indicate future subclinical renal issues
    (HealthDay)—Gestational diabetes mellitus (GDM) may be an early indicator of subsequent subclinical renal dysfunction, according to a study published online May 4 in Diabetes Care. Read more »
  • Boosting the effects of vitamin D to tackle diabetes
    More than 27 million people in the United States are living with type 2 diabetes, according to the Centers for Disease Control and Prevention. As the population ages and a growing percentage of people become overweight or obese, that number is expected to increase. Read more »
  • Diabetes-associated pain linked to disrupted insulin signalling
    The chronic pain experienced by a number of patients with diabetes has widely been assumed to originate from damage to blood vessels or to local tissue surrounding neurons caused by high blood-sugar levels. However, a new study reports that in fruit flies, this pain hypersensitivity results instead from disrupted insulin signalling in pain sensory neurons. Read more »
  • Lesbian, bisexual women may be more likely to develop diabetes due to stress
    In a newly published study involving 94,250 women across the United States, researchers found that lesbian and bisexual (LB) women were more likely than heterosexual women to develop type 2 diabetes during the course of the 24-year study follow up. Read more »
  • Type 2 diabetes ups risk of renal cancer in women, but not men
    (HealthDay)—Type 2 diabetes is independently associated with a greater risk of renal cell carcinoma (RCC) in women, but not in men, according to a study published online April 20 in Diabetes Care. Read more »
  • New device could mean end of the jab for people living with diabetes
    Researchers from The University of Western Australia are testing the effectiveness of a device in the long-term treatment of the low blood glucose form of diabetes and are in need of community participants for the study. Read more »
  • Community health worker-led intervention beneficial in T2DM
    (HealthDay)—A community health worker (CHW)-led diabetes self-management education (DSME) program is associated with sustained improvement in hemoglobin A1c (HbA1c), according to a study published online April 27 in Diabetes Care. Read more »
Pin It